Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 6/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.56 |
| ▸ | RAB9A | P51151 | 3/20 | 0.56 |
| ▸ | NPC1 | O15118 | 2/20 | 0.56 |
| ▸ | TP53 | P04637 | 2/20 | 0.54 |
| ▸ | MAPT | P10636 | 2/20 | 0.54 |
| ▸ | CYP1A2 | P05177 | 5/20 | 0.53 |
| ▸ | CYP2C19 | P33261 | 4/20 | 0.53 |
| ▸ | CYP2D6 | P10635 | 4/20 | 0.53 |
| ▸ | CLK4 | Q9HAZ1 | 4/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.53 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.53 |
| ▸ | TSHR | P16473 | 3/20 | 0.53 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.53 |
| ▸ | USP2 | O75604 | 2/20 | 0.50 |
| ▸ | EGFR | P00533 | 2/20 | 0.50 |
| ▸ | ERBB3 | P21860 | 2/20 | 0.50 |
| ▸ | TNNI3K | Q59H18 | 1/20 | 0.48 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.47 |
| ▸ | PDGFRB | P09619 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL414719 | 0.86 | MEN1 (0.70) | MEN1KMT2ARAB9ANPC1TP53 | |
| SCHEMBL3431925 | 0.78 | CDK1 (0.60) | MEN1KMT2ARAB9ANPC1TP53 | |
| SCHEMBL27322736 | 0.77 | CFD (0.47) | MEN1KMT2ARAB9ANPC1TP53 | |
| SCHEMBL19420148 | 0.77 | THRB (0.70) | MAPTTSHREGFRTNNI3KKDM4E | |
| SCHEMBL857502 | 0.77 | NPC1 (0.63) | MEN1KMT2ARAB9ANPC1TP53 | |
| SCHEMBL18559680 | 0.77 | MEN1 (0.56) | MEN1KMT2ARAB9ANPC1TP53 | |
| SCHEMBL25387375 | 0.77 | KMO (0.54) | MEN1KMT2ARAB9ANPC1TP53 | |
| SCHEMBL3226900 | 0.77 | KMO (0.66) | MEN1KMT2ARAB9ANPC1TP53 | |
| Hydrochloric Acid SCHEMBL2176643 | 0.76 | NPC1 (0.61) | MEN1KMT2ARAB9ANPC1TP53 | |
| SCHEMBL2305280 | 0.76 | TP53 (0.74) | MEN1KMT2ARAB9ANPC1TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1877481-B1 | STABILISER COMPOSITION FOR HALIDE-CONTAINING POLYMERS | SUN ACE KAKOH PTE LTD (SG) | 2016-02-17 | — | — | EP | disclosed |
| US-20140107100-A1 | Benzoxazepines as Inhibitors of PI3K/mTOR and Methods of Their Use and Manufacture | EXELIXIS, INC. (US) | 2014-04-17 | — | — | US | disclosed |
| US-20140080810-A1 | Benzoxazepines as Inhibitors of PI3K/mTOR and Methods of Their Use and Manufacture | EXELIXIS, INC. (US) | 2014-03-20 | — | — | US | disclosed |
| US-8648066-B2 | Benzoxazepines as inhibitors of PI3K/mTOR and methods of their use and manufacture | EXELIXIS, INC. (US) | 2014-02-11 | — | — | US | disclosed |
| CN-103459384-A | Benzoxazepines as inhibitors of PI3K/mTOR and methods of their use and manufacture | EXELIXIS INC | 2013-12-18 | — | — | CN | disclosed |
| EP-2640366-A2 | BENZOXAZEPINES AS INHIBITORS OF PI3K/MTOR AND METHODS OF THEIR USE AND MANUFACTURE | Exelixis, Inc. (US) | 2013-09-25 | — | — | EP | disclosed |
| CN-101203556-B | Stabiliser composition for chlorine-containing polymers | SUN ACE KAKOH PTE LTD | 2012-06-27 | — | — | CN | disclosed |
| WO-2012068096-A2 | BENZOXAZEPINES AS INHIBITORS OF PI3K/MTOR AND METHODS OF THEIR USE AND MANUFACTURE | EXELIXIS, INC. (US) | 2012-05-24 | — | — | WO | disclosed |
| CN-102459249-A | Benzoxazepines based p13k/mt0r inhibitors against proliferative diseases | EXELIXIS INC | 2012-05-16 | — | — | CN | disclosed |
| EP-2432779-A1 | BENZOXAZEPINES BASED P13K/MT0R INHIBITORS AGAINST PROLIFERATIVE DISEASES | Exelixis, Inc. (US) | 2012-03-28 | — | — | EP | disclosed |
| US-7842743-B2 | Stabiliser composition for halide-containing polymers | SUN ACE KAKOH (PTE.) LTD. (SG) | 2010-11-30 | — | — | US | disclosed |
| US-20100298290-A1 | Benzoxazepines as Inhibitors of PI3K/mTOR and Methods of Their Use and Manufacture | EXELIXIS, INC. (US) | 2010-11-25 | — | — | US | disclosed |
| WO-2010135524-A1 | BENZOXAZEPINES BASED P13K/MT0R INHIBITORS AGAINST PROLIFERATIVE DISEASES | EXELIXIS, INC. (US) | 2010-11-25 | — | — | WO | disclosed |
| US-20090030123-A1 | STABILISER COMPOSITION FOR HALIDE-CONTAINING POLYMERS | SUN ACE KAKOH (PTE.) LTD. (SG) | 2009-01-29 | — | — | US | disclosed |
| CN-101203556-A | Stabiliser composition for chlorine-containing polymers | SUN ACE KAKOH PTE LTD (SG) | 2008-06-18 | — | — | CN | disclosed |
| EP-1877481-A2 | STABILISER COMPOSITION FOR HALIDE-CONTAINING POLYMERS | Sun Ace Kakoh (Pte.) Ltd. (SG) | 2008-01-16 | — | — | EP | disclosed |
| WO-2006110112-A2 | STABILISER COMPOSITION FOR HALIDE-CONTAINING POLYMERS | SUN ACE KAKOH (PTE.) LTD. (SG) | 2006-10-19 | — | — | WO | disclosed |
| WO-2006110106-A1 | STABILISER COMPOSITION FOR CHLORINE-CONTAINING POLYMERS | SUN ACE KAKOK (PTE.) LTD. (SG) | 2006-10-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100298290-A1 | Benzoxazepines as Inhibitors of PI3K/mTOR and Methods of Their Use and Manufacture | MTOR, RICTOR, PIK3CA | MEN1 3183/4885KMT2A 2645/4885RAB9A 1023/4885 |
| US-20140107100-A1 | Benzoxazepines as Inhibitors of PI3K/mTOR and Methods of Their Use and Manufacture | MTOR, RICTOR, PIK3CA | MEN1 2920/4885KMT2A 2282/4885RAB9A 720/4885 |
| US-20140080810-A1 | Benzoxazepines as Inhibitors of PI3K/mTOR and Methods of Their Use and Manufacture | MTOR, RICTOR, PIK3CA | MEN1 3264/4885KMT2A 3064/4885RAB9A 1064/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.